2015•Future OncologyRequires access
Obesity, Lymphadenectomy and Survival Outcomes in Intermediate to High-Risk, Early-Stage Endometrial Cancer Patients
Faina Y. Linkov, Robert P. Edwards, Andrew D. Althouse, Jose Alejandro Rauh‐Hain, Marcela G.del Carmen, Kyle E. Freese, Joseph Leo Kelley, Alexander Babatunde Olawaiye
Open publisher page 0 citations
Abstract
AIM: Lymphadenectomy or lymph node dissection is a topic of controversy in endometrial cancer (EC) treatment. MATERIALS & METHODS: Associations between lymph node dissections and clinical factors were retrospectively examined in obese, endometrioid endometrial cancer patients with early-stage disease between 1995 and 2005. Overall, EC-specific and recurrence-free survival were also evaluated. RESULTS: Out of 192 patients, 61 (32%) did not have a lymph node examination, 55 (29%) had less than ten lymph nodes removed and 76 (39%) had ≥10 removed. Lymph node dissection count was not significantly associated with overall, EC-specific or recurrence-free survival. CONCLUSION: Analysis revealed no significant associations between ≥10 dissected lymph nodes and survival outcomes among obese, EC patients, which supports the need for additional investigation of the merit of lymphadenectomy among these patients.